DGAP-News

RHÖN-KLINIKUM AG: Interim Report for the First Quarter of 2015: financial year begins strongly for RHÖN-KLINIKUM AG - research and quality offensive strengthens our market position in cutting-edge healthcare - Seite 2

actual procedure, exact time and financial aspects of the repurchase is
still outstanding. In the course of distributing the sales proceeds the
shareholders already had the opportunity in Autumn 2014 through a share
repurchase programme with subsequent capital reduction to offer their
shares to the Company. With an ultimate offer rate of approx. 98.4 % and
together with last year's dividend roughly EUR 1.7 billion has already been
distributed to the shareholders with this instrument.

Outlook

We expect revenues of EUR 1.08 billion to EUR 1.12 billion and EBITDA of
between EUR 145 million and EUR 155 million for 2015, the first full
financial year with the new portfolio structure. As in 2013 and 2014
one-off effects will continue to influence the corporate results during
this financial year as well. The size of these positive and negative
special influences is a low two-digit million figure; they will be priced
in gradually over the entire financial year 2015 and will partially cancel
each other out.

"We have successfully stayed our course for organic growth in the first
three months of the current financial year. Our focus is on medical
innovations and new therapies as well as modern equipment and procedures
for the benefit of our patients. We are therefore increasing our research
and development budget accordingly in order to strengthen our unique
standing in the market. Innovation projects with a total volume of roughly
EUR 4 million will be financed at all our locations within the corporate
group in the next few months," CEO Dr. Dr. Martin Siebert stated. Since 1st
January 2015 all Group locations either have university hospital status or
act as academic teaching hospitals with a close link to science, research
and training. Furthermore Siebert referred to the fact that the planned
hospital reform envisages payment of medical services based on quality
indications. "We have also done our homework with respect to quality. Our
hospitals will certainly benefit if this criterion does indeed become
relevant for the calculation of fees."

**************************************************************************

RHÖN-KLINIKUM AG AG is one of the largest healthcare providers in Germany.
With ten hospitals in five locations and a total of 5,300 beds we offer
affordable cutting-edge medical care with a direct link to universities and
research institutes. Our facilities are located in Bad Berka, Bad
Neustadt/Saale, Frankfurt (Oder) and Giessen and Marburg. A total of over